TMC278LA

rilpivirine long-acting formulation

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for TMC278LA, covering 2010-08-16 to 2018-07-26. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure Prophylaxis [Phase 2]

See pricing